News Headline Summary

For Seattle Genetics (SGEN), Health Canada OKs Adcetris for treatment of relapsed Hodgkin Lymphoma

Reaction details (19:10)

- Co. shares moved 0.8% higher in reaction to this news to hit a high at USD 29.78; trades USD 29.72 last.

01 Feb 2013 - 19:08 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: